Legal Representation
Attorney
BASSAM N. IBRAHIM
USPTO Deadlines
Application History
50 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Mar 24, 2025 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | Loading... |
| Mar 24, 2025 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Dec 4, 2024 | CNFR | W | SU - FINAL REFUSAL - WRITTEN | Loading... |
| Dec 4, 2024 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Dec 4, 2024 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Oct 30, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Oct 30, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Aug 26, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jun 12, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jun 3, 2024 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Jun 3, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jun 3, 2024 | CNRT | W | SU - NON-FINAL ACTION - WRITTEN | Loading... |
| May 24, 2024 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| May 15, 2024 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Oct 18, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 16, 2023 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Oct 16, 2023 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Oct 16, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| May 12, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| May 10, 2023 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| May 10, 2023 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| May 10, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Dec 8, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Dec 8, 2022 | NOAC | E | CORRECTED NOA E-MAILED | Loading... |
| Dec 7, 2022 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Dec 7, 2022 | DPCC | D | DIVISIONAL PROCESSING COMPLETE | Loading... |
| Nov 23, 2022 | ERTD | I | TEAS REQUEST TO DIVIDE RECEIVED | Loading... |
| Nov 23, 2022 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Nov 23, 2022 | DRRR | I | DIVISIONAL REQUEST RECEIVED | Loading... |
| Nov 23, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jul 21, 2022 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| May 13, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| May 11, 2022 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| May 11, 2022 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| May 11, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jan 7, 2022 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Jan 7, 2022 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jan 7, 2022 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Dec 14, 2021 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Nov 4, 2021 | CORV | P | REVIEW OF CORRESPONDENCE COMPLETE | Loading... |
| Nov 3, 2021 | ISPO | Z | WITHDRAWN FROM ISSUE - PETITIONS OFFICE REQUEST | Loading... |
| Nov 2, 2021 | APET | A | ASSIGNED TO PETITION STAFF | Loading... |
| Nov 1, 2021 | ISPO | Z | WITHDRAWN FROM ISSUE - PETITIONS OFFICE REQUEST | Loading... |
| Oct 26, 2021 | EPPA | I | TEAS POST PUBLICATION AMENDMENT RECEIVED | Loading... |
| Oct 26, 2021 | D1BR | I | TEAS DELETE 1(B) BASIS RECEIVED | Loading... |
| Oct 19, 2021 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Oct 19, 2021 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Sep 29, 2021 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Sep 27, 2021 | EXPT | T | EXPARTE APPEAL TERMINATED | Loading... |
| Sep 15, 2021 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for human use, namely, pharmaceutical antibodies or its fragments or its derivatives; cells that manufacture antibodies, fragments of antibodies or derivatives of antibodies for medical use
First Use Anywhere:
20210000
First Use in Commerce:
20210000
Classification
International Classes
005